Sage Rhino Capital LLC Vertex Pharmaceuticals Inc Transaction History

Sage Rhino Capital LLC

$439 Million
Q3 2024

A detailed history of Sage Rhino Capital LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sage Rhino Capital LLC holds 520 shares of VRTX stock, worth $241,571. This represents 0.05% of its overall portfolio holdings.

Number of Shares

520

Previous 546 4.76%

Holding current value

$241,571

Previous $255,000 5.49%

% of portfolio

0.05%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$460.0 - $505.78 $11,960 - $13,150	-26 Reduced 4.76%	520 $241,000
Q2 2024 Jul 30, 2024	SELL	$392.81 - $485.53 $4,713 - $5,826	-12 Reduced 2.15%	546 $255,000
Q1 2024 Apr 26, 2024	BUY	$407.69 - $446.08 $2,038 - $2,230	5 Added 0.9%	558 $233,000
Q4 2023 Feb 05, 2024	SELL	$343.0 - $410.68 $18,522 - $22,176	-54 Reduced 8.9%	553 $225,000
Q3 2023 Oct 26, 2023	SELL	$338.18 - $362.46 $1,352 - $1,449	-4 Reduced 0.65%	607 $211,000
Q2 2023 Jul 31, 2023	BUY	$314.42 - $351.91 $192,110 - $215,017	611 New	611 $215,000
Q2 2022 Jul 28, 2022	SELL	$234.96 - $292.55 $128,993 - $160,609	-549 Reduced 37.02%	934 $263,000
Q1 2022 Apr 27, 2022	SELL	$221.42 - $260.97 $19,484 - $22,965	-88 Reduced 5.6%	1,483 $387,000
Q4 2021 Feb 04, 2022	BUY	$177.01 - $223.45 $4,779 - $6,033	27 Added 1.75%	1,571 $345,000
Q3 2021 Oct 18, 2021	BUY	$181.39 - $202.99 $4,171 - $4,668	23 Added 1.51%	1,544 $280,000
Q2 2021 Jul 27, 2021	BUY	$187.49 - $221.1 $1,499 - $1,768	8 Added 0.53%	1,521 $307,000
Q1 2021 May 04, 2021	BUY	$207.02 - $241.31 $54,860 - $63,947	265 Added 21.23%	1,513 $325,000
Q4 2020 Feb 03, 2021	BUY	$207.01 - $276.09 $24,013 - $32,026	116 Added 10.25%	1,248 $295,000
Q3 2020 Nov 05, 2020	BUY	$255.65 - $303.1 $23,264 - $27,582	91 Added 8.74%	1,132 $308,000
Q2 2020 Jul 30, 2020	BUY	$225.48 - $295.8 $6,087 - $7,986	27 Added 2.66%	1,041 $302,000
Q1 2020 Apr 29, 2020	SELL	$199.77 - $247.81 $1,198 - $1,486	-6 Reduced 0.59%	1,014 $241,000
Q4 2019 Jan 31, 2020	BUY	$166.71 - $223.91 $170,044 - $228,388	1,020 New	1,020 $234,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Account

Sage Rhino Capital LLC Vertex Pharmaceuticals Inc Transaction History